StockTalk: Biotechs set to boom with clinical trial floodgates open
Link copied to
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses the performance of the biotech sector.
Populating the experts panel this week is Jacquie Palmer, managing director of Pharmaceutical Solutions, Nina Webster, CEO and managing director of Dimerix (ASX:DXB) and Dr Ross Macdonald, CEO and managing director of Cynata Therapeutics (ASX:CYP).
The group discusses a range of topics, including opening of the biotech ‘clinical trial floodgates’, how the industry will fare in the wake of the pandemic and which sub-sectors look likely to perform best in the new investment landscape.
So tune in above to hear the panel discuss these topics and more.